Announce Date | 11/04/2024 |
EPS Normalized Actual | $-0.00013 (Beat by $0.12987) |
EPS GAAP Actual | $-0.00013 (Beat by $0.12987) |
Revenue Actual | $0.01227B |
Revenue Surprise | Beat by $12.27M |
Announce Date | 10/01/2024 (Pre-Market) |
EPS Normalized Estimate | $-0.09 |
EPS GAAP Estimate | $-0.09 |
Revenue Estimate | $0.0125855B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0.66 | 7.5 | 0.61289 | 0.73738 | 0 |
Dec 2027 | 0.29 | 17.07 | 0.2693 | 0.324 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.32 | -0.32 | 0.01227B | 9.36% | 12.27M |
FQ4 2021 (Dec 2021) | -0.72 | -0.72 | 0.011078B | 35.47% | 11.08M |
FQ3 2021 (Sep 2021) | -0.37 | -0.37 | 0.013287B | 37.83% | 13.29M |
FQ2 2021 (Jun 2021) | -0.33 | -0.33 | 0.015345B | -41.25% | 15.35M |
FQ1 2021 (Mar 2021) | -0.41 | -0.41 | 0.011122B | 21.19% | 11.12M |
FQ4 2020 (Dec 2020) | -0.6 | -0.6 | 0.007149B | -129.67% | 7.15M |
FQ3 2020 (Sep 2020) | -0.49 | -0.49 | 0.00826B | -50.34% | 8.26M |
FQ2 2020 (Jun 2020) | -0.07 | -0.07 | 0.021675B | 48.66% | 21.68M |
FQ4 Announce Date
10/01/2024 (Pre-Market)
Consensus EPS Estimates
-0.09
Consensus Revenue Estimates
0.0125855B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | -0.095 | -- | -0.0990404 | -0.09076488 | 2 |
FQ3 2025 (Jul 2025) | -0.095 | -- | -0.0990404 | -0.09076488 | 2 |
FQ2 2025 (Jun 2025) | -0.095 | -- | -0.09965391 | -0.09152182 | 2 |
FQ1 2025 (Mar 2025) | -0.09 | -- | -0.09440896 | -0.08670488 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.01B | -- | 0.01B | 0.01B | 2 |
FQ3 2025 (Jul 2025) | 0.01B | -- | 0.01B | 0.01B | 2 |
FQ2 2025 (Jun 2025) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ1 2025 (Mar 2025) | 0.01B | -- | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.32 | -0.32 | 100% | |
FQ4 2021 (Dec 2021) | -0.72 | -0.72 | 100% | |
FQ3 2021 (Sep 2021) | -0.37 | -0.37 | 100% | |
FQ2 2021 (Jun 2021) | -0.33 | -0.33 | 100% | |
FQ1 2021 (Mar 2021) | -0.41 | -0.41 | 100% | |
FQ4 2020 (Dec 2020) | -0.6 | -0.6 | 100% | |
FQ3 2020 (Sep 2020) | -0.49 | -0.49 | 100% | |
FQ2 2020 (Jun 2020) | -0.07 | -0.07 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.01B | $12.27M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.01B | $11.08M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.01B | $13.29M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.02B | $15.35M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.01B | $11.12M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.01B | $7.15M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.01B | $8.26M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.02B | $21.68M | 100% |